Excessive intravenous crystalloid infusion after video-assisted thoracoscopic surgery lobectomy is associated with postoperative pneumonia

J Cardiothorac Surg. 2019 Nov 29;14(1):209. doi: 10.1186/s13019-019-1024-6.

Abstract

Background: Video-assisted thoracoscopic surgery has been widely used in thoracic surgery worldwide. Our goal was to identify the risk factors for postoperative pneumonia in patients undergoing video-assisted thoracoscopic surgery lobectomy.

Methods: A retrospective analysis of adult patients undergoing video-assisted thoracoscopic surgery lobectomy between 2016 and 05 and 2017-04 was performed. We used univariate analyses and multivariate analyses to examine risk factors for postoperative pneumonia after lobectomy.

Results: The incidence of postoperative pneumonia was 19.7% (n = 143/727). Patients with postoperative pneumonia had a higher postoperative length of stay and total hospital care costs when compared to those without postoperative pneumonia. Multivariate analysis showed that body mass index grading ≥24.0 kg/m2 (vs. <24.0 kg/m2: odds ratio 1.904, 95% confidence interval 1.294-2.802, P = 0.001) and right lung lobe surgery (vs. left lung lobe surgery: odds ratio 1.836, 95% confidence interval 1.216-2.771, P = 0.004) were independent risk factors of postoperative pneumonia. Total intravenous crystalloid infusion grading in the postoperative 24 h ≥ 1500 mL was also identified as the risk factors (vs. 1000 to < 1500 mL: odds ratio 2.060, 95% confidence interval 1.302-3.260, P = 0.002).

Conclusions: Major risk factors for postoperative pneumonia following video-assisted thoracoscopic surgery lobectomy are body mass index grading ≥24.0 kg/m2, right lung lobe surgery and total intravenous crystalloid infusion grading in the postoperative 24 h ≥ 1500 mL.

Keywords: Lobectomy; Postoperative pneumonia; Risk factors; Video-assisted thoracoscopic surgery lobectomy.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • China / epidemiology
  • Crystalloid Solutions / administration & dosage
  • Crystalloid Solutions / adverse effects*
  • Female
  • Humans
  • Incidence
  • Infusions, Intravenous
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged
  • Pneumonectomy / adverse effects*
  • Pneumonia / chemically induced*
  • Pneumonia / diagnosis
  • Pneumonia / epidemiology
  • Postoperative Complications / chemically induced*
  • Postoperative Complications / diagnosis
  • Postoperative Complications / epidemiology
  • Retrospective Studies
  • Risk Factors
  • Thoracic Surgery, Video-Assisted / adverse effects*

Substances

  • Crystalloid Solutions